FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039704382> ?p ?o ?g. }

• W3039704382 endingPage "4810" @default.
• W3039704382 startingPage "4793" @default.
• W3039704382 abstract "Platinum resistance is a major challenge in the management of ovarian cancer. Even low levels of acquired resistance at the cellular level lead to impaired response to cisplatin. In ovarian cancer intraperitoneal therapy, nanoparticle formulation can improve the cisplatin's pharmacokinetics and safety profile.This work aimed to investigate the chemo-sensitivity of ovarian cancer SKOV3 cells upon short-term (72h) single treatment of cisplatin and cisplatin-loaded biodegradable nanoparticles (Cis-NP). The aim was then to determine the therapeutic properties of Cis-NP in vivo using a SKOV3-luc cells' xenograft model in mice.Cell cytotoxicity was assessed after the exposure of the cell culture to cisplatin or Cis-NP. The effect of treatments on EMT and CSC-like phenotype was studied by analyzing a panel of markers by flow cytometry. Intracellular platinum concentration was determined by inductively coupled plasma mass spectrometry (ICS-MS), and gene expression was evaluated by RNAseq analysis. The efficacy of intraperitoneal chemotherapy was evaluated in a SKOV3-luc cells' xenograft model in mice, through a combination of bioluminescence imaging, histological, and immunohistochemical analyses.We observed in vitro that short-term treatment of cisplatin has a critical role in determining the potential induction of chemoresistance, and a nanotechnology-based drug delivery system can modulate it. The RNAseq analysis underlines a protective effect of nanoparticle system according to their ability to down-regulate several genes involved in chemoresistance, cell proliferation, and apoptosis. The highest intracellular platinum concentration obtained with Cis-NP treatment significantly improved the efficacy. Consistent with in vitro results, we found that Cis-NP treatment in vivo can significantly reduce tumor burden and aggressiveness compared to the free drug.Nanoparticle-mediated cisplatin delivery may serve as an intracellular depot impacting the cisplatin pharmacodynamic performance at cellular levels. These features may contribute to improving the drawbacks of conventional intraperitoneal therapy, and therefore will require further investigations in vivo." @default.
• W3039704382 created "2020-07-10" @default.
• W3039704382 creator A5010557824 @default.
• W3039704382 creator A5025590600 @default.
• W3039704382 creator A5032166923 @default.
• W3039704382 creator A5052251472 @default.
• W3039704382 creator A5056963397 @default.
• W3039704382 creator A5065898407 @default.
• W3039704382 creator A5079213910 @default.
• W3039704382 creator A5080724845 @default.
• W3039704382 creator A5081125141 @default.
• W3039704382 creator A5083863497 @default.
• W3039704382 creator A5091233863 @default.
• W3039704382 creator A5091403708 @default.
• W3039704382 date "2020-07-01" @default.
• W3039704382 modified "2023-10-14" @default.
• W3039704382 title "<p>Nanotechnology-Based Cisplatin Intracellular Delivery to Enhance Chemo-Sensitivity of Ovarian Cancer</p>" @default.
• W3039704382 cites W1957462776 @default.
• W3039704382 cites W1966051785 @default.
• W3039704382 cites W1981572581 @default.
• W3039704382 cites W2016599680 @default.
• W3039704382 cites W2028593825 @default.
• W3039704382 cites W2029069130 @default.
• W3039704382 cites W2031079863 @default.
• W3039704382 cites W2038417739 @default.
• W3039704382 cites W2053124055 @default.
• W3039704382 cites W2063764833 @default.
• W3039704382 cites W2068138131 @default.
• W3039704382 cites W2080823856 @default.
• W3039704382 cites W2089682625 @default.
• W3039704382 cites W2089818916 @default.
• W3039704382 cites W2093402539 @default.
• W3039704382 cites W2106448082 @default.
• W3039704382 cites W2113174758 @default.
• W3039704382 cites W2115954319 @default.
• W3039704382 cites W2124185479 @default.
• W3039704382 cites W2130177169 @default.
• W3039704382 cites W2144771139 @default.
• W3039704382 cites W2152574852 @default.
• W3039704382 cites W2154589460 @default.
• W3039704382 cites W2166667895 @default.
• W3039704382 cites W2269087069 @default.
• W3039704382 cites W2399911066 @default.
• W3039704382 cites W2423221830 @default.
• W3039704382 cites W2503957764 @default.
• W3039704382 cites W2519930924 @default.
• W3039704382 cites W2521517273 @default.
• W3039704382 cites W2522431784 @default.
• W3039704382 cites W2560138732 @default.
• W3039704382 cites W2611115350 @default.
• W3039704382 cites W2611412386 @default.
• W3039704382 cites W2617696599 @default.
• W3039704382 cites W2620731633 @default.
• W3039704382 cites W2701973945 @default.
• W3039704382 cites W2757348926 @default.
• W3039704382 cites W2766094141 @default.
• W3039704382 cites W2771491442 @default.
• W3039704382 cites W2794264057 @default.
• W3039704382 cites W2887628002 @default.
• W3039704382 cites W2896238142 @default.
• W3039704382 cites W2898000086 @default.
• W3039704382 cites W2899807241 @default.
• W3039704382 cites W2910959534 @default.
• W3039704382 cites W2942804183 @default.
• W3039704382 cites W2952102703 @default.
• W3039704382 cites W3012995596 @default.
• W3039704382 cites W4210987384 @default.
• W3039704382 doi "https://doi.org/10.2147/ijn.s247114" @default.
• W3039704382 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7368240" @default.
• W3039704382 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32764921" @default.
• W3039704382 hasPublicationYear "2020" @default.
• W3039704382 type Work @default.
• W3039704382 sameAs 3039704382 @default.
• W3039704382 citedByCount "17" @default.
• W3039704382 countsByYear W30397043822021 @default.
• W3039704382 countsByYear W30397043822022 @default.
• W3039704382 countsByYear W30397043822023 @default.
• W3039704382 crossrefType "journal-article" @default.
• W3039704382 hasAuthorship W3039704382A5010557824 @default.
• W3039704382 hasAuthorship W3039704382A5025590600 @default.
• W3039704382 hasAuthorship W3039704382A5032166923 @default.
• W3039704382 hasAuthorship W3039704382A5052251472 @default.
• W3039704382 hasAuthorship W3039704382A5056963397 @default.
• W3039704382 hasAuthorship W3039704382A5065898407 @default.
• W3039704382 hasAuthorship W3039704382A5079213910 @default.
• W3039704382 hasAuthorship W3039704382A5080724845 @default.
• W3039704382 hasAuthorship W3039704382A5081125141 @default.
• W3039704382 hasAuthorship W3039704382A5083863497 @default.
• W3039704382 hasAuthorship W3039704382A5091233863 @default.
• W3039704382 hasAuthorship W3039704382A5091403708 @default.
• W3039704382 hasBestOaLocation W30397043821 @default.
• W3039704382 hasConcept C109316439 @default.
• W3039704382 hasConcept C121608353 @default.
• W3039704382 hasConcept C126322002 @default.
• W3039704382 hasConcept C150903083 @default.
• W3039704382 hasConcept C178790620 @default.
• W3039704382 hasConcept C185592680 @default.
• W3039704382 hasConcept C190283241 @default.

• next